Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ISRG
Barclays Thinks Intuitive Surgical Is Still Worth $650
Stocks Hitting 52-Week Highs
TransEnterix moving closer to launch of SurgiBot System; shares down 18% premarket on profit taking (Seeking Alpha)
Related BCRX
Oppenheimer Analysts Express Conflicting Sentiment On Sarepta, BioCryst
Benzinga's Top Downgrades
BioCryst Hit With A HAE-Maker (Seeking Alpha)

Analysts at ISI Group initiated coverage on shares of Intuitive Surgical (NASDAQ: ISRG) with a “strong buy” rating. The target price for Intuitive Surgical is set to $50. Intuitive Surgical's shares closed at $430.14 on Friday.

Analysts at Roth Capital initiated coverage on shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) with a “buy” rating. The target price for BioCryst Pharmaceuticals is set to $18. BioCryst Pharmaceuticals' shares closed at $10.80 on Friday.

Morgan Stanley initiated coverage on shares of ARAMARK Holdings (NYSE: ARMK) with an “overweight” rating. The target price for ARAMARK Holdings is set to $29. ARAMARK's shares closed at $24.51 on Friday.

Deutsche Bank initiated coverage on shares of Hilton Worldwide (NYSE: HLT) with a “buy” rating. The target price for Hilton Worldwide is set to $27. Hilton Worldwide's shares closed at $22.25 on Friday.

Latest Ratings for ISRG

DateFirmActionFromTo
Jan 2016Morgan StanleyUpgradesEqual-weightOverweight
Nov 2015CitigroupInitiates Coverage onBuy
Jul 2015Canaccord GenuityUpgradesBuy

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (BCRX + ARMK)

Get Benzinga's Newsletters